Population
Patients with atrial fibrillation
Authors
Loading...
May indicate persistent warfarin underuse in AF; leaves open questions on implementation barriers.
Warfarin use in atrial fibrillation has not increased recently, indicating inadequate implementation of this therapy and a need to address barriers in real-world practice.
Stafford et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: